Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(6):757–759. doi: 10.1038/bjc.1997.457

Low frequency of allelic loss in skin tumours from immunosuppressed individuals.

I Rehman 1, A G Quinn 1, M Takata 1, A E Taylor 1, J L Rees 1
PMCID: PMC2228045  PMID: 9310241

Abstract

Organ transplant recipients receiving immunosuppression show a dramatically increased risk of non-melanoma skin cancer. The cause of this increase is not known. We report that the rate of loss of heterozygosity (at all the loci we examined) was significantly lower in tumours from immunosuppressed individuals than in tumours from immunocompetent subjects [20 out of 148 (14%) vs 157 out of 428 (37%); P< 0.0001]. These results suggest that tumours in immunosuppressed individuals have a different molecular pathogenesis.

Full text

PDF
757

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel E. A. Cutaneous manifestations of immunosuppression in organ transplant recipients. J Am Acad Dermatol. 1989 Aug;21(2 Pt 1):167–179. doi: 10.1016/s0190-9622(89)70157-2. [DOI] [PubMed] [Google Scholar]
  2. Barr B. B., Benton E. C., McLaren K., Bunney M. H., Smith I. W., Blessing K., Hunter J. A. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet. 1989 Jan 21;1(8630):124–129. doi: 10.1016/s0140-6736(89)91143-4. [DOI] [PubMed] [Google Scholar]
  3. Boshoff C., Talbot S., Kennedy M., O'Leary J., Schulz T., Chang Y. HHV8 and skin cancers in immunosuppressed patients. Lancet. 1996 Feb 3;347(8997):338–339. doi: 10.1016/s0140-6736(96)90524-3. [DOI] [PubMed] [Google Scholar]
  4. Busby-Earle R. M., Steel C. M., Bird C. C. Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies. Br J Cancer. 1993 Jan;67(1):71–75. doi: 10.1038/bjc.1993.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Busby-Earle R. M., Steel C. M., Williams A. R., Cohen B., Bird C. C. Papillomaviruses, p53, and cervical cancer. Lancet. 1992 May 30;339(8805):1350–1350. [PubMed] [Google Scholar]
  6. Crook T., Wrede D., Vousden K. H. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene. 1991 May;6(5):873–875. [PubMed] [Google Scholar]
  7. España A., Redondo P., Fernández A. L., Zabala M., Herreros J., Llorens R., Quintanilla E. Skin cancer in heart transplant recipients. J Am Acad Dermatol. 1995 Mar;32(3):458–465. doi: 10.1016/0190-9622(95)90069-1. [DOI] [PubMed] [Google Scholar]
  8. Glover M. T., Deeks J. J., Raftery M. J., Cunningham J., Leigh I. M. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet. 1997 Feb 8;349(9049):398–398. doi: 10.1016/S0140-6736(97)80015-3. [DOI] [PubMed] [Google Scholar]
  9. Hartevelt M. M., Bavinck J. N., Kootte A. M., Vermeer B. J., Vandenbroucke J. P. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation. 1990 Mar;49(3):506–509. doi: 10.1097/00007890-199003000-00006. [DOI] [PubMed] [Google Scholar]
  10. Kinlen L. J., Sheil A. G., Peto J., Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979 Dec 8;2(6203):1461–1466. doi: 10.1136/bmj.2.6203.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kinzler K. W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996 Oct 18;87(2):159–170. doi: 10.1016/s0092-8674(00)81333-1. [DOI] [PubMed] [Google Scholar]
  12. London N. J., Farmery S. M., Will E. J., Davison A. M., Lodge J. P. Risk of neoplasia in renal transplant patients. Lancet. 1995 Aug 12;346(8972):403–406. doi: 10.1016/s0140-6736(95)92780-8. [DOI] [PubMed] [Google Scholar]
  13. Rehman I., Takata M., Wu Y. Y., Rees J. L. Genetic change in actinic keratoses. Oncogene. 1996 Jun 20;12(12):2483–2490. [PubMed] [Google Scholar]
  14. Stark L. A., Arends M. J., McLaren K. M., Benton E. C., Shahidullah H., Hunter J. A., Bird C. C. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer. 1994 Feb;69(2):222–229. doi: 10.1038/bjc.1994.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tieben L. M., Berkhout R. J., Smits H. L., Bouwes Bavinck J. N., Vermeer B. J., Bruijn J. A., Van der Woude F. J., Ter Schegget J. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol. 1994 Aug;131(2):226–230. doi: 10.1111/j.1365-2133.1994.tb08496.x. [DOI] [PubMed] [Google Scholar]
  16. Vousden K. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. FASEB J. 1993 Jul;7(10):872–879. doi: 10.1096/fasebj.7.10.8393818. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES